Table 4.
Clinicopathological comparison of WDNEC and PDNEC
WDNEC (n = 4) | PDNEC (n = 7) | |
---|---|---|
Vascularity in pancreas tumor | ||
Yes (%) | 50 % (2/4) | 0 % (0/7) |
Ki67 labeling index | ||
Median (range) | 46.3 % (40–53 %) | 85 % (54–95 %) |
Rb immunopositivity | 100 % (4/4) | 14 % (1/7) |
KRAS mutation | 0 % (0/4) | 86 % (6/7) |
Response rate of platinum-based regimen | 0 % (0/2) | 100 % (4/4) |
Prognosis | ||
Median | 227 days | 186 days |
WDNEC well-differentiated NEC, PDNEC poorly differentiated NEC